Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Recent research has suggested that GLP-1 agonists used to treat obesity might be associated with a stroke in the optic nerve, but association is not the same as causation
What the EMA Found and Why It Matters The EMAs Pharmacovigilance Risk Assessment Committee (PRAC) completed an exhaustive review of semaglutide, including data from clinical trials, post-marketing surveillance, non-clinical studies, and medical literature, and concluded that NAION is a very rare but real adverse effect of taking semaglutide
For everything else better sleep, recovery, muscle gain, fat loss the boring answer is the right answer
Compound Versions of Weight-Loss Drugs Will Soon No Longer Be Allowed, FDA Rules, ABC News, 2025
Beyond weight reduction, tirzepatide improved multiple metabolic markers including fasting glucose, HbA1c levels, blood pressure, and lipid profiles in study participants
Taking multiple GLP medicines together can increase the risk of side effects without necessarily improving results
